AlphaFold and Beyond: Predicting Viral Protein Structures for Antiviral Target Discovery

Introduction

The determination of three-dimensional protein structures has long been a rate-limiting step in antiviral drug development. Experimental methods such as X-ray crystallography, cryo-electron microscopy (cryo-EM), and nuclear magnetic resonance (NMR) spectroscopy remain indispensable, but they are resource-intensive and often fail for transient or poorly expressed viral proteins. The advent of deep learning-based structure prediction, exemplified by AlphaFold2 and RoseTTAFold, has fundamentally altered this landscape [1, 2]. These methods now provide atomic-level models for entire viral proteomes, enabling structure-guided antiviral target discovery at unprecedented speed and scale [3, 1]. For veterinary virology, where emerging pathogens such as highly pathogenic avian influenza H5N1, African swine fever virus (ASFV), and novel coronaviruses pose continuous threats, the ability to rapidly generate reliable structural models is critical for identifying conserved druggable sites and designing small-molecule inhibitors [4, 2].

This article reviews the technical foundations of AlphaFold and related deep learning predictors, their application to viral protein classes relevant to veterinary medicine, and the integration of predicted models into computational workflows for antiviral target discovery. Emphasis is placed on validation against experimental structures, inherent limitations, and the synergistic use of predicted models with molecular dynamics simulations and docking algorithms.

The Deep Learning Paradigm for Protein Structure Prediction

AlphaFold2 employs an end-to-end neural network architecture that directly predicts atomic coordinates from a multiple sequence alignment (MSA) and a template library [2]. The core innovation is the use of an attention-based mechanism (Evoformer) that iteratively refines pairwise residue representations and a structure module that outputs torsion angles and backbone coordinates. RoseTTAFold, a three-track neural network, simultaneously processes sequence, distance, and coordinate information in a single architecture [1]. Both methods achieve near-experimental accuracy for single-domain proteins, with median backbone root-mean-square deviation (RMSD) values below 1 Å when compared to crystallographic structures [2].

The Big Fantastic Virus Database (BFVD) exemplifies the large-scale application of these methods to virology. BFVD contains over 7 million predicted protein structures from more than 100,000 viral species, generated using AlphaFold2 and RoseTTAFold [2]. This repository provides a structural foundation for identifying conserved domains, such as the WIV domain found in arthropod viruses, which likely facilitates infection by mediating membrane interactions [5]. The availability of such databases accelerates the discovery of novel antiviral targets by enabling comparative structural analysis across viral families [2].

Applications to Veterinary Viral Proteins

Spike and Envelope Glycoproteins

Viral envelope glycoproteins mediate host cell attachment and membrane fusion, making them primary targets for neutralizing antibodies and entry inhibitors. AlphaFold2 has been extensively applied to model the spike (S) proteins of coronaviruses, including those of bat origin and livestock-associated strains [4]. For example, the transmembrane (TM) domain of SARS-CoV-2 nonstructural protein 3 (nsp3) contains a conserved pore-forming region (TM2-Y) that is structurally maintained across coronaviruses and even beyond the family, suggesting a potential target for broad-spectrum inhibitors [4]. Predicted models of this region have enabled docking studies to identify small molecules that occlude the pore [4].

In the context of avian influenza, hemagglutinin (HA) structures predicted by AlphaFold2 have been used to map receptor-binding site conformations and to assess the impact of mutations on host range [1]. The computational modeling of HA dynamics, combined with deep mutational scanning, allows the prediction of antigenic drift and the identification of conserved epitopes that are less prone to escape [1]. Cross-reference to the article on Structural Prediction of Viral Envelope Glycoproteins Using AlphaFold2 provides further detail on receptor-binding analysis.

Polymerase Complexes and Replication Machinery

Viral RNA-dependent RNA polymerases (RdRps) are essential for genome replication and are validated targets for nucleoside analog inhibitors. AlphaFold2 has been used to model the RdRp of ASFV, a large DNA virus that causes devastating outbreaks in swine. The predicted structure of the ASFV polymerase catalytic subunit reveals a canonical right-hand fold with conserved motifs, and docking simulations have identified binding poses for existing polymerase inhibitors [3]. Similarly, the polymerase complex of influenza A virus (including avian strains) has been modeled to study the interaction with host factors and to design inhibitors that disrupt cap-snatching activity [1]. The article on Structural and Computational Analysis of African Swine Fever Virus Capsid Proteins for Antiviral Drug Design discusses related capsid targets.

Capsid and Structural Proteins

Capsid proteins protect the viral genome and are often involved in assembly and uncoating. For non-enveloped viruses, the capsid surface is the primary interface for host cell recognition. AlphaFold2 predictions of ASFV major capsid protein p72 have been validated against cryo-EM reconstructions, showing excellent agreement in the core jelly-roll fold [3]. Predicted models of the capsid have been used to identify surface-exposed loops that may be targeted by antiviral peptides [3]. The WIV domain, identified in a wide range of arthropod viruses, is another example of a structurally conserved capsid-associated domain that likely facilitates infection [5]. Its predicted structure reveals a beta-sandwich fold with a conserved hydrophobic patch, suggesting a role in membrane disruption [5].

Antiviral Target Discovery Using Predicted Structures

Docking and Virtual Screening

Predicted protein structures serve as receptors for molecular docking campaigns. The Interactys-AI framework integrates AlphaFold2 models with protein-protein interaction (PPI) networks to map virus-host interfaces and identify repurposable antiviral compounds [3]. This approach has been applied to model the attachment of HIV to human cells, demonstrating that predicted structures of viral envelope glycoproteins can be used to dock small molecules that block receptor binding [6]. For veterinary viruses, similar pipelines can be constructed using host orthologs (e.g., swine ACE2 for porcine coronaviruses) [3].

Identification of Cryptic Binding Pockets

One of the most valuable contributions of predicted structures is the discovery of cryptic pockets: transient cavities that are not apparent in experimental apo structures but become druggable upon ligand binding. AlphaFold2 models, when combined with molecular dynamics simulations, can reveal such pockets in viral proteins. For example, the TM2-Y region of coronavirus nsp3 contains a cryptic pore that is lined by conserved hydrophobic residues, making it a promising target for small-molecule blockers [4]. The structural conservation of this region across coronaviruses and related viruses suggests that inhibitors targeting this pore could have broad-spectrum activity [4].

Peptide and Protein Binder Design

Predicted structures also enable the computational design of peptide inhibitors and protein binders. Using AlphaFold2 models of viral fusion proteins, researchers have designed peptides that mimic the heptad repeat regions of class I fusion proteins, thereby inhibiting membrane fusion [1]. The article on Computational Design of Broad-Spectrum Antiviral Peptides Targeting Viral Fusion Proteins provides a detailed methodology. Additionally, AI-based binder design tools such as RFdiffusion and ProteinMPNN can generate de novo proteins that bind to predicted viral epitopes with high affinity [1].

The following Mermaid diagram summarizes a typical workflow from viral sequence to antiviral target identification using predicted structures.

flowchart TD
    A[Viral Genome Sequence], > B[Multiple Sequence Alignment]
    B, > C[AlphaFold2 / RoseTTAFold Prediction]
    C, > D[Predicted 3D Structure]
    D, > E[Validation against Experimental Data]
    E, > F[Structure-Based Virtual Screening]
    E, > G[Cryptic Pocket Detection via MD]
    E, > H[Protein-Protein Interface Mapping]
    F, > I[Small-Molecule Inhibitor Candidates]
    G, > I
    H, > J[Peptide / Binder Design]
    I, > K[In Vitro / In Vivo Testing]
    J, > K

Validation and Limitations

Despite remarkable accuracy, predicted structures have well-documented limitations. AlphaFold2 performs poorly on intrinsically disordered regions, which are common in viral proteins and often mediate host interactions [1]. Multi-chain complexes, such as the influenza polymerase heterotrimer, are challenging because AlphaFold2 was trained primarily on single-chain inputs; however, recent versions (AlphaFold-Multimer) have improved performance for protein-protein interfaces [2]. Additionally, predicted models represent a single low-energy conformation and may miss functionally relevant alternative states, such as the pre-fusion and post-fusion conformations of viral glycoproteins [1].

Validation against experimental structures remains essential. The BFVD repository includes confidence metrics (pLDDT and PAE) that guide users in selecting reliable regions for downstream analysis [2]. For veterinary applications, cross-referencing predicted models with cryo-EM maps of related viruses (e.g., ASFV p72) provides a critical quality check [3]. The article on Molecular Dynamics Simulations of Viral Envelope Protein Conformational Changes discusses how simulations can complement static predictions by exploring conformational ensembles.

Integration with Other Computational Methods

Predicted structures are most powerful when integrated with other computational techniques. Molecular dynamics (MD) simulations can relax predicted models, assess stability, and capture conformational transitions relevant to drug binding [1]. Deep mutational scanning (DMS) data can be mapped onto predicted structures to identify residues that are both functionally important and structurally accessible [1]. Machine learning models that predict variant effects on protein stability can be combined with AlphaFold2 models to prioritize mutations that may confer drug resistance [1]. The article on Deep Learning for Predicting Antiviral Resistance Mutations in Influenza Neuraminidase illustrates this synergy.

Furthermore, AI-driven protein binder design tools (e.g., RFdiffusion, ProteinMPNN) can use predicted viral structures as templates to generate high-affinity binders that neutralize the virus [1]. These binders can then be optimized through directed evolution or further computational design. The article on AI Protein Binder Design Tools provides a comprehensive overview.

Future Directions

The next generation of deep learning predictors, including AlphaFold3, extends predictions to protein-ligand and protein-nucleic acid complexes, enabling direct modeling of drug-target interactions [1]. For veterinary virology, this capability will allow the simultaneous prediction of viral protein structures and their binding poses with candidate inhibitors, streamlining the drug discovery pipeline. Additionally, the integration of predicted structures with host-pathogen interaction networks, as demonstrated by the Interactys-AI framework, will facilitate the identification of host-directed antiviral targets [3].

The growing repository of predicted viral structures, such as BFVD, will continue to expand as new viruses are discovered through metagenomic surveillance [2]. This structural knowledge, combined with AI-driven analysis of viral evolution and host range, will enhance pandemic preparedness for both human and animal health [1]. Cross-reference to the article on Deep Learning for Predicting Viral Host-Range Transitions and Zoonotic Potential for further reading.

Conclusion

Deep learning-based protein structure prediction has transformed structural virology by providing rapid, accurate models of viral proteins that are otherwise difficult to characterize experimentally. AlphaFold2 and RoseTTAFold, supported by large-scale repositories like BFVD, enable the identification of conserved druggable pockets, the design of small-molecule inhibitors and peptide binders, and the mapping of virus-host interfaces. While limitations remain, particularly for disordered regions and multi-conformational states, the integration of predicted structures with molecular dynamics, deep mutational scanning, and AI-based binder design creates a powerful computational platform for antiviral target discovery in veterinary medicine.

References

[1] Sinno A, Baghdadi R, Narch R, et al. Charting the virosphere: computational synergies of AI and bioinformatics in viral discovery and evolution. J Virol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41222234/

[2] Kim RS, Levy Karin E, Mirdita M, et al. BFVD-a large repository of predicted viral protein structures. Nucleic Acids Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39574394/

[3] Poitras C, Harake A, Grandvaux N, et al. Interactys-AI: Toward AI-Driven Structural Mapping of Virus-Host Interfaces for Antiviral Repurposing and Pandemic Preparedness. Biomolecules. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42072662/

[4] Pozhidaeva A, Hoch JC, Pustovalova Y. The DMV pore-forming TM2-Y region of SARS-CoV-2 nsp3 exhibits structural conservation beyond the coronavirus family. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41930969/

[5] Karlin DG. WIV, a protein domain found in a wide number of arthropod viruses, which probably facilitates infection. J Gen Virol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38193819/

[6] Davydenko VS, Shchemelev AN, Ostankova YV, et al. Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41303692/

[7] Fernández-Lainez C, de la Mora-de la Mora I, Enríquez-Flores S, et al. The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation in a Structure-Dependent Fashion via Toll-like Receptors. Int J Mol Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36232855/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.